Monoclonal antibody therapy for Crohn's disease.
Selby
W
W
Department of Medicine, University of Sydney and Royal Prince Alfred Hospital, New South Wales, Australia. warwicks@mail.med.usyd.edu.au
D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000009:adverse effects; D003424:Crohn Disease / Q000188:drug therapy*; D005765:Gastrointestinal Agents / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D000069285:Infliximab; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab